Highly sensitive automated chemiluminometric assay for measuring free human glandular kallikrein-2

Clinical Chemistry

Volumn 45, Issue 6 I, 1999, Pages 800-806

  Klee, George G ^a   Goodmanson, Marcia K ^a   Jacobsen, Steven J ^a   Young, Charles Y F ^a   Finlay, Judith A ^b   Rittenhouse, Harry G ^b   Wolfert, Robert L ^b   Tindall, Donald J ^a  

^a MAYO CLINIC   (United States)

^b Hybritech Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KALLIKREIN; MONOCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; AUTOANALYSIS; CANCER DIAGNOSIS; CLINICAL LABORATORY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; PROSTATE DISEASE;

EID: 0032995422     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.6.800     Document Type: Article

References (30)

1. Young CY-F, Andrews PE, Montgomery BT, Tindall DF. Tissue-specific and hormonal regulation of human prostatic-specific glandular kallikrein, Biochemistry 1992;31:818-24.
2. Henttu P, Vihko P. Prostate-specific antigen and human glandular kallikrein: two kallikreins of the human prostate. Ann Med 1994; 25:157-64.
3. McCormack RT, Rittenhouse HG, Finlay JA, Sokoloff RL, Wang TJ, Wolfert RL, et al. Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology 1995;45: 729-44.
4. Rittenhouse HG, Finlay JA, Mikolajczyk SD, Partin AW. Human kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit Rev Clin Lab Sci 1998;35:275-368.
5. Pannek J, Rittenhouse HG, Evans CL, Finlay JA, Bruzek DJ, Cox JJ, et al. Molecular forms of prostate specific antigen and human kallikrein (hK2) in urine are not clinically useful for early detection and staging of prostate cancer. Urology 1997;50:715-21.
6. Darson MF, Pacelli A, Roche PC, Rittenhouse HG, Wolfert RL, Young CY-F, et al. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker. Urology 1997;49:857-62.
7. Piironen T, Lovgren J, Karp M, Eerola R, Lundwall A, Dowell B, et al. Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serum. Clin Chem 1996;42:1034-41.
8. Klee G, Griffin B, Young C, Tindall D, Finlay J, Saedi M. A competitive chemiluminescent assay for a PSA homologue-human glandular kallikrein (hK2) [Abstract]. Clin Chem 1995;41: S220.
9. Saedi MS, Cass MMJ, Goel AS, Grauer LS, Hogan KL, Okaneya T, et al. Overexpression of a human prostate-specific glandular kallikrein, hK2, in E. coli and generation of antibodies. Mol Cell Endocrinol 1995;109:237-41.
10. Kumar A, Mikolajczyk SD, Goel AS, Millar LS, Saedi MS. Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2. Cancer Res 1997;57:3111-4.
11. Finlay JA, Evans C, Day JR, Payne JK, Mikolajczyk SD, Millar LS, et al. Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate specific antigen cross-reactivity. Urology 1998;51:804-9.
12. Charlesworth MC, Young CY, Klee GG, Saedi MS, Mikolajczyk SD, Finlay JA, Tindall DJ. Detection of a prostate-specific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levels. Urology 1997;49:487-93.
13. Mikolajczyk SD, Millar LS, Marker KM, Grauer LS, Goel A, Cass MMJ, et al. Ala217 is important for the catalytic function and autoactivation of prostate-specific human kallikrein 2. Eur J Biochem 1997;246:440-6.
14. Weeks I, Beheshti I, McCapra F, Campbell AK, Woodhead JS. Acridinium esters as high-specific-activity labels in immunoassay. Clin Chem 1983;29:1474-9.
15. Ngo TT. Enzyme systems and enzyme conjugates for solid-phase ELISA. In: Butler JE, ed. Immunochemistry of solid-phase immunoassay. Boca Raton, FL: CRC Press, 1991:85-102.
16. Mikolajczyk SD, Millar LS, Kumar A, Saedi MS. Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors. Prostate 1998;34: 44-50.
17. Wang TJ, Hill TM, Sokoloff RL, Frankenne F, Rittenhouse HG, Wolfert RL. Dual monoclonal antibody immunoassay for free prostate-specific antigen. Prostate 1996;28:10-6.
18. 1-antichymotrypsin in plasma. Clin Chem 1993;39:869-74.
19. 1-antichymotrypsin: purification and properties. Biochemistry 1978;17:5647-51.
20. Stamey TA, Teplow DB, Graves HCB. Identity of PSA purified from seminal fluid by different methods: comparison by amino acid analysis and assigned extinction coefficients. Prostate 1995;27: 198-203.
21. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, Lieber MM. Serum prostate-specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges. JAMA 1993;270:860-4.
22. O'Brien PC, Dyck PJ. Procedures for setting normal values. Neurology 1995;45:17-23.
23. Bridon DP, Dowell BL. Structural comparison of prostate-specific antigen and human glandular kallikrein using molecular modeling. Urology 1995;45:801-6.
24. Grauer LS, Finlay JA, Mikolajczyk SD, Pusateri KD, Wolfert RL. Detection of human glandular kallikrein, hK2, as its precursor form and in complex with protease inhibitors in prostate carcinoma serum. J Androl 1998;19:407-11.
25. Christensson A, Laurell CB, Lilja H. Enzymatic activity of prostatic-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem 1990;194:755-63.
26. 2-macroglobulin. Clin Chem 1998;44:2471-9.
27. Strobel S, Smith K, Wolfert R, Rittenhouse H. Role of free PSA in discordance across commercial PSA assays. Clin Chem 1996;42: 645-7.
28. Kumar A, Mikolajczyk SD, Goel AS, Millar LS, Saedi MS. Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2. Cancer Res 1997;57:3111-4.
29. Tremblay RR, Coulombe E, Cloutier S, Brunet C, Deperthes D, Frenette G, Dube JY. Assessment of the trypsin-like human prostatic kallikrein, also known as hK2, in the seminal plasma of infertile men: respective contributions of an ELISA procedure and of Western blotting. J Lab Clin Med 1998;131:330-5.
30. Kwiatowski MK, Recker F, Piironen T, Pettersson K, Otto T, Wernli M, Tscholl R. In prostatism patients, the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA of 4 to 10 ng/mL. Urology 1998;52:360-5.